A double-blind cross-over evaluation of ketoprofen (Orudis) and ibuprofen in the management of rheumatoid arthritis. 1979

F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli

In a multi-centre double-blind cross-over trial using the double-placebo technique, 55 patients with rheumatoid arthritis were treated for 10 days for each trial drug with ketoprofen (200 mg/day) and ibuprofen (1200 mg/day). Both drugs induced a clinically and statistically significant improvement of all the symptoms studied, except for pain at night during ibuprofen administration. Ketoprofen displayed a therapeutic efficacy significantly superior to ibuprofen in five of the eight symptoms studied. Side-effects were recorded in 10 patients receiving ketoprofen (one patient withdrew because of heartburn) and in nine patients receiving ibuprofen.

UI MeSH Term Description Entries
D007052 Ibuprofen A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties Advil,Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester,Brufen,Ibumetin,Ibuprofen, (+-)-Isomer,Ibuprofen, (R)-Isomer,Ibuprofen, (S)-Isomer,Ibuprofen, Aluminum Salt,Ibuprofen, Calcium Salt,Ibuprofen, Copper (2+) Salt,Ibuprofen, Magnesium Salt,Ibuprofen, Potassium Salt,Ibuprofen, Sodium Salt,Ibuprofen, Zinc Salt,Ibuprofen-Zinc,Motrin,Nuprin,Rufen,Salprofen,Trauma-Dolgit Gel,alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid,Ibuprofen Zinc,Trauma Dolgit Gel
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, Rheumatology and rehabilitation,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
October 1973, British medical journal,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, Scandinavian journal of rheumatology. Supplement,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, Scandinavian journal of rheumatology. Supplement,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, Rheumatology and rehabilitation,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1975, Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, Scandinavian journal of rheumatology. Supplement,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, The Journal of international medical research,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
May 1973, Rheumatology and rehabilitation,
F Montrone, and M Fumagalli, and P Pellegrini, and G Ratti, and G Sala, and C Liverta, and C Pollini, and A E Pontiroli
January 1976, Scandinavian journal of rheumatology. Supplement,
Copied contents to your clipboard!